Ryan Montier

Title: The Innovative Contributions of Ryan Montier

Introduction

Ryan Montier is an accomplished inventor based in Camas, Washington. He has made significant strides in the field of cancer treatment through his innovative research and patent contributions. His work focuses on the utilization of specific T cells for the identification and treatment of tumors.

Latest Patents

Ryan Montier holds a patent titled "Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer." This patent outlines methods for treating subjects with tumors by administering a therapeutically effective amount of CD8CD39CD103 T cells. The methods also include isolating a nucleic acid encoding a T cell receptor (TCR) that specifically binds to tumor cell antigens. Furthermore, the patent describes techniques for expanding CD8CD39CD103 T cells and determining if a subject will respond to checkpoint inhibitors by detecting the presence of these T cells in biological samples.

Career Highlights

Throughout his career, Ryan Montier has worked with notable organizations, including Providence Health & Services in Oregon and Agonox, Inc. His experience in these institutions has contributed to his expertise in cancer research and treatment methodologies.

Collaborations

Ryan has collaborated with esteemed colleagues such as Andrew D. Weinberg and Thomas Duhen. These partnerships have further enhanced his research and development efforts in the field of oncology.

Conclusion

Ryan Montier's innovative work in cancer treatment through his patent on T cell utilization showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his collaborations with other professionals highlight the importance of teamwork in research.